65.49

5.73% 3.55

After Hours: 65.49

Haemonetics Corp (HAE)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Haemonetics Corp stock is traded at $65.49, with a volume of 1.04M. It is up +5.73% in the last 24 hours and up +7.13% over the past month. Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Previous Close:

$61.94

Open:

$64.49

24h Volume:

1.04M

Relative Volume:

1.32

Market Cap:

$2.98B

Revenue:

$1.32B

Net Income/Loss:

$175.44M

P/E Ratio:

17.99

EPS:

3.6395

Net Cash Flow:

$308.08M

1W Performance:

+16.34%

1M Performance:

+7.13%

6M Performance:

-16.88%

1Y Performance:

-1.01%

1-Day Range:

$63.59

$65.84

1-Week Range:

$55.75

$65.84

52-Week Range:

$47.31

$87.32

Haemonetics Corp Stock (HAE) Company Profile

Name

Haemonetics Corp

Sector

Healthcare (1108)

Industry

Medical Devices (143)

Phone

(781) 848-7100

Address

125 SUMMER STREET, BOSTON, MA

Employee

3,009

Twitter

@HaemoneticsCorp

Next Earnings Date

2026-05-07

Latest SEC Filings

HAE's Discussions on Twitter

Compare HAE vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HAE Haemonetics Corp	65.49	2.81B	1.32B	175.44M	308.08M	3.6395
ABT Abbott Laboratories	87.41	152.88B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	316.48	120.18B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	78.60	100.34B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	57.78	84.95B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	85.78	47.91B	6.30B	1.07B	1.09B	1.8406

Haemonetics Corp Stock (HAE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-15-25	Downgrade	Needham	Buy → Hold
Dec-11-25	Downgrade	Citigroup	Buy → Neutral
Aug-11-25	Downgrade	Raymond James	Strong Buy → Outperform
Aug-08-25	Reiterated	Barrington Research	Outperform
Aug-08-25	Downgrade	JP Morgan	Overweight → Neutral
Jul-09-25	Upgrade	Citigroup	Neutral → Buy
Jun-26-25	Initiated	Robert W. Baird	Outperform
Feb-07-25	Downgrade	BofA Securities	Neutral → Underperform
Dec-06-24	Initiated	JP Morgan	Overweight
Nov-08-24	Upgrade	Raymond James	Outperform → Strong Buy
Sep-13-24	Initiated	CL King	Buy
Sep-11-24	Initiated	BofA Securities	Neutral
Sep-10-24	Initiated	BTIG Research	Buy
Jun-12-24	Upgrade	Needham	Hold → Buy
Oct-13-22	Initiated	Mizuho	Buy
Jan-27-22	Downgrade	Needham	Buy → Hold
Dec-15-21	Downgrade	Citigroup	Buy → Neutral
Aug-17-21	Resumed	Raymond James	Outperform
Jun-17-21	Initiated	Citigroup	Buy
May-14-21	Upgrade	CJS Securities	Market Perform → Market Outperform
Apr-20-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-19-21	Downgrade	CJS Securities	Market Outperform → Market Perform
Feb-03-21	Upgrade	Barrington Research	Mkt Perform → Outperform
Jan-21-21	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-05-20	Upgrade	Barrington Research	Mkt Perform → Outperform
May-06-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-31-20	Upgrade	CJS Securities	Market Perform → Market Outperform
Jan-10-20	Initiated	Needham	Buy
Aug-07-19	Reiterated	Barrington Research	Outperform
May-14-19	Upgrade	Raymond James	Mkt Perform → Outperform
May-08-19	Reiterated	Barrington Research	Outperform
Aug-09-18	Reiterated	Barrington Research	Outperform
Feb-07-18	Reiterated	Barrington Research	Outperform
Jan-02-18	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-08-17	Reiterated	Barrington Research	Outperform
Aug-08-17	Upgrade	Barrington Research	Mkt Perform → Outperform
Jul-13-17	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Feb-07-17	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-08-16	Upgrade	Barrington Research	Mkt Perform → Outperform
Nov-07-16	Reiterated	The Benchmark Company	Hold
Sep-20-16	Downgrade	CJS Securities	Market Outperform → Market Perform
Aug-15-16	Downgrade	Sidoti	Buy → Neutral
Aug-02-16	Reiterated	Jefferies	Buy
Aug-02-16	Reiterated	The Benchmark Company	Hold

View All

Haemonetics Corp Stock (HAE) Latest News

May 24, 2026

Is It Time To Reassess Haemonetics (HAE) After The Recent Share Price Jump - simplywall.st

May 24, 2026

May 22, 2026

Medical Devices & SuppliesSpecialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE) - Yahoo Finance

May 22, 2026

Investing in Haemonetics (HAE)? Don't Miss Assessing Its International Revenue Trends - Yahoo! Finance Canada

May 22, 2026

This Texas Instruments Analyst Turns Bullish; Here Are Top 4 Upgrades For Friday - Benzinga

May 22, 2026

BofA upgrades Haemonetics stock rating on conservative guidance - Investing.com

May 22, 2026

HAE Stock Price, Quote & Chart | HAEMONETICS CORP/MASS (NYSE:HAE) - ChartMill

May 22, 2026

May 21, 2026

Is It Too Late to Buy Haemonetics Corp (HAE) After 4.0% Rally? G - GuruFocus

May 21, 2026

Does Haemonetics (HAE) Have Enduring Growth Potential? - Insider Monkey

May 21, 2026

May 20, 2026

Q3 2026 Haemonetics Corp Earnings Call Transcript - GuruFocus

May 20, 2026

Haemonetics Corp 2026 Annual Report: Business Overview, Market Segments, Products, and Competitive Landscape - Minichart

May 20, 2026

Haemonetics (NYSE: HAE) outlines segment shifts, major customers and risks - Stock Titan

May 20, 2026

May 19, 2026

Haemonetics (HAE) EVP and General Counsel receives 28,424 RSUs, 2,913 shares withheld for taxes - Stock Titan

May 19, 2026

[Form 4] HAEMONETICS CORP Insider Trading Activity - Stock Titan

May 19, 2026

Haemonetics (NYSE: HAE) CFO granted 29,312 RSUs with tax withholding - Stock Titan

May 19, 2026

Haemonetics (NYSE: HAE) VP granted 2,220 RSUs, 197 shares withheld for tax - Stock Titan

May 19, 2026

Haemonetics (HAE) EVP Roy Galvin granted RSUs as 879 shares withheld for taxes - Stock Titan

May 19, 2026

Haemonetics (HAE) SVP granted RSUs while shares withheld to cover taxes - Stock Titan

May 19, 2026

Haemonetics (HAE) CEO receives 78,344 RSUs and has shares withheld for taxes - Stock Titan

May 19, 2026

May 18, 2026

Does Haemonetics' (HAE) Buyback-Funded Loss Quarter Hint at Shifting Earnings Quality Priorities? - simplywall.st

May 18, 2026

May 17, 2026

Haemonetics (HAE) Valuation Check As Earnings Pressure And Options Volatility Raise Questions - simplywall.st

May 17, 2026

May 15, 2026

Haemonetics (HAE) Q4 2026 Earnings Transcript - AOL.com

May 15, 2026

May 14, 2026

Haemonetics Sees FY27 Revenue, Adjusted EPS Up 4%-7% >HAE - Moomoo

May 14, 2026